10-Q Filing

TENET HEALTHCARE CORP CIK: 70318 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001558370-17-003181`
Period End Date	20170331
Filing Date	20170501
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	thc-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 69 Cash Flow Statement 83 Comprehensive Income 19

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.03B	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.04B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.93B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization (in dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.97B	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$772.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$728.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Other intangible assets, accumulated amortization (in dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$814.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($1,041 at March 31, 2017 and $1,031 at December 31, 2016)	`AccountsReceivableNetCurrent`	$2.96B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($1,041 at March 31, 2017 and $1,031 at December 31, 2016)	`AccountsReceivableNetCurrent`	$2.90B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$326.00M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$324.00M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	148.11M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	148.84M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$4.00M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$26.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$29.00M	USD	Point-in-time
Common stock in treasury, shares	`TreasuryStockCommonShares`	48.42M	shares	Point-in-time
Common stock in treasury, shares	`TreasuryStockCommonShares`	48.42M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.28B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.17B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.05B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.26B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.25B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.26B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$930.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$871.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,926 at March 31, 2017 and $4,974 at December 31, 2016)	`PropertyPlantAndEquipmentNet`	$7.98B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,926 at March 31, 2017 and $4,974 at December 31, 2016)	`PropertyPlantAndEquipmentNet`	$8.05B	USD	Point-in-time
Goodwill	`Goodwill`	$7.42B	USD	Point-in-time
Goodwill	`Goodwill`	$7.43B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($814 at March 31, 2017 and $772 at December 31, 2016)	`IntangibleAssetsNetExcludingGoodwill`	$1.86B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($814 at March 31, 2017 and $772 at December 31, 2016)	`IntangibleAssetsNetExcludingGoodwill`	$1.84B	USD	Point-in-time
Total assets	`Assets`	$24.51B	USD	Point-in-time
Total assets	`Assets`	$24.70B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$147.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$191.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.18B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.33B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$739.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$872.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$181.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$201.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$210.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$327.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$9.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$11.00M	USD	Point-in-time
Accrued legal settlement costs	`LitigationReserveCurrent`	$8.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.16B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.23B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.77B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.03B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$15.07B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$15.06B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$613.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$614.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$626.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$624.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$289.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$279.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$621.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$610.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.99B	USD	Point-in-time
Total liabilities	`Liabilities`	$21.23B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.43B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.39B	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 148,840,473 shares issued at March 31, 2017 and 148,106,249 shares issued at December 31, 2016	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 148,840,473 shares issued at March 31, 2017 and 148,106,249 shares issued at December 31, 2016	`CommonStockValue`	$7.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.83B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.83B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-258.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-255.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.74B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.74B	USD	Point-in-time
Common stock in treasury, at cost, 48,419,483 shares at March 31, 2017 and 48,420,650 shares at December 31, 2016	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Common stock in treasury, at cost, 48,419,483 shares at March 31, 2017 and 48,420,650 shares at December 31, 2016	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$430.00M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$417.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$665.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$664.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$926.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$24.70B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$24.51B	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$5.42B	USD	1 Quarter
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$5.20B	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$376.00M	USD	1 Quarter
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$383.00M	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$5.04B	USD	1 Quarter
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$4.81B	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$24.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$29.00M	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.40B	USD	1 Quarter
Salaries, wages and benefits	`LaborAndRelatedExpense`	$2.38B	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$765.00M	USD	1 Quarter
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$811.00M	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.19B	USD	1 Quarter
Other operating expenses, net	`OtherCostAndExpenseOperating`	$1.24B	USD	1 Quarter
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$-1.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$212.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$221.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$33.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$28.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-5.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-173.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$147.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$15.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$267.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$354.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$258.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$243.00M	USD	1 Quarter
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-6.00M	USD	1 Quarter
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	1 Quarter
Net income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.00M	USD	1 Quarter
Net income from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$105.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-33.00M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$67.00M	USD	1 Quarter
Net income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$38.00M	USD	1 Quarter
Net income from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$37.00M	USD	1 Quarter
Net loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-5.00M	USD	1 Quarter
Net loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Income tax benefit	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	1 Quarter
Income tax benefit	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	1 Quarter
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-4.00M	USD	1 Quarter
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$34.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$93.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$89.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-53.00M	USD	1 Quarter
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-52.00M	USD	1 Quarter
Net loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-55.00M	USD	1 Quarter
Net loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-4.00M	USD	1 Quarter
Net loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.00M	USD	1 Quarter
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-53.00M	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.56	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.52	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.04	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	1 Quarter
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.53	USD	1 Quarter
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.60	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.52	USD	1 Quarter
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.56	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	1 Quarter
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.04	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.53	USD	1 Quarter
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.60	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	100.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	98.77M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	100.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.77M	shares	1 Quarter

Cash Flow Statement 83 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$34.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$212.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$221.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$376.00M	USD	1 Quarter
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$383.00M	USD	1 Quarter
Deferred income tax expense	`DeferredIncomeTaxExpenseBenefit`	$31.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$13.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$16.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$33.00M	USD	1 Quarter
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$28.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-5.00M	USD	1 Quarter
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-173.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$147.00M	USD	1 Quarter
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$15.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`UndistributedEarnings`	$-4.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`UndistributedEarnings`	$-12.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$10.00M	USD	1 Quarter
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$11.00M	USD	1 Quarter
Pre-tax loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-2.00M	USD	1 Quarter
Pre-tax loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-5.00M	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$-2.00M	USD	1 Quarter
Other items, net	`OtherNoncashIncomeExpense`	$2.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$446.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$453.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$18.00M	USD	1 Quarter
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$-132.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$34.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-28.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-114.00M	USD	1 Quarter
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-161.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$26.00M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$24.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$24.00M	USD	1 Quarter
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$69.00M	USD	1 Quarter
Net cash provided by (used in) operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-3.00M	USD	1 Quarter
Net cash provided by (used in) operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$2.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$186.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$147.00M	USD	1 Quarter
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$208.00M	USD	1 Quarter
Purchases of property and equipment - continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$198.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$29.00M	USD	1 Quarter
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$573.00M	USD	1 Quarter
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$20.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$12.00M	USD	1 Quarter
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$9.00M	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$18.00M	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$1.00M	USD	1 Quarter
Other assets	`PaymentsForProceedsFromProductiveAssets`	$12.00M	USD	1 Quarter
Other assets	`PaymentsForProceedsFromProductiveAssets`	$10.00M	USD	1 Quarter
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$1.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-189.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$320.00M	USD	1 Quarter
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$995.00M	USD	1 Quarter
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$995.00M	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$38.00M	USD	1 Quarter
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$89.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$1.00M	USD	1 Quarter
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$6.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$2.00M	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$63.00M	USD	1 Quarter
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$44.00M	USD	1 Quarter
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$10.00M	USD	1 Quarter
Proceeds from employee stock plan purchases	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.00M	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	1 Quarter
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-14.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-95.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-141.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-144.00M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$372.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$728.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$728.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$572.00M	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$132.00M	USD	1 Quarter
Interest paid, net of capitalized interest	`InterestPaidNet`	$130.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$6.00M	USD	1 Quarter
Income tax payments, net	`IncomeTaxesPaidNet`	$1.00M	USD	1 Quarter

Comprehensive Income 19 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$36.00M	USD	1 Quarter
Net income	`ProfitLoss`	$34.00M	USD	1 Quarter
Amortization of net actuarial loss included in other non-operating income (expense), net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$4.00M	USD	1 Quarter
Unrealized gains on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$2.00M	USD	1 Quarter
Unrealized gains on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$3.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$3.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$2.00M	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$5.00M	USD	1 Quarter
Other comprehensive income before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$9.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$6.00M	USD	1 Quarter
Income tax expense related to items of other comprehensive income	`OtherComprehensiveIncomeLossTax`	$1.00M	USD	1 Quarter
Total other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	1 Quarter
Total other comprehensive income, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$3.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$38.00M	USD	1 Quarter
Comprehensive net income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$39.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$89.00M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$93.00M	USD	1 Quarter
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-50.00M	USD	1 Quarter
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-55.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.